However, Kobayashi et al. (22) evaluated patients with PSA levels between 2.6 and 4.0 ng/ mL and reported no significant difference between PSAD and PSATZ in terms of their accuracy in detecting prostate cancer. The gene discussed is KLK3; the disease is Familial prostate cancer.